skip to: main content | section menu | full site menu

Technology Transfer from the University of Oxford

Pharmaceutical

The following technologies are available for licensing in this group:

Technology Updates

In order to keep in touch with people and organisations interested in Isis' technologies, we provide regular email updates on new technologies. Request Technology Updates.

Project number 66 - Chiral Peptide Nucleic Acids

Project number 508 - Trimerising Polypeptides - A Platform Technology

Project number 689 - Therapeutic Tolerogenic Antibodies

Project number 957 - Controlled Drug Release

Project number 1206 - Commercial opportunity in Anti-Cancer Treatment

Project number 1223 - T Cell Sensitivity

Project number 1288 - Improved Viral Vectors for Gene Therapy and Vaccination

Project number 1428 - Improved Vaccination Using Lentivirus in Prime/Boost Protocols

Project number 1439 - Suppression of Transplant Rejection

Project number 1441 - CDK2/Cyclin A

Project number 1444 - Novel Paediatric Vaccine Adjuvant

Project number 1475 - Suppressing auto-reactivity with antibodies that augment inhibitory receptor function

Project number 1506 - Next Generation, High-Throughput Phage Display

Project number 1538 - Comprehensive Meningococcal Vaccine

Project number 1549 - A Neurotrophic Compound in Treatment of Depression

Project number 1566 - Ankyrin Repeat Proteins

Project number 2101 - Improved T-Cell Immune Response

Project number 2452 - Recombinant Overlapping Peptide Vaccines for Infectious Disease and Cancer

Project number 2664 - Assays for Anti-Cancer Agents

Project number 2791 - Transfection Reagent Adjuvant

Project number 2805 - DNA Nanotetrahedra for drug delivery

Project number 2816 - Allergen Specific T-cell Clones for Antibody testing

Project number 2839 - A New Treatment for Neurodegenerative Disease

Project number 2932 - Molecular Shape Recognition

Project number 2947 - Low Water Bioreactor

Project number 3096 - Novel Porphyrin Dimers in Photodynamic Therapy

Project number 3101 - A Novel Cancer Biomarker and Drug Target

Project number 3195 - QuantiSNP Software for copy number Variant ID

Project number 3203 - A Prognostic Test for Breast CAncer

Project number 3303 - Novel Microspheres Drug Delivery to Bone

Project number 3310 - High Density protein Nanoarray

Project number 3337 - HLA Typing

Project number 3435 - Anti-thrombotic Treatment

Project number 10491 - Recombinant Alphavirus for DNA Vaccination

Project number 10492 - Tetramer Reagents for Monitoring an Immune Response

Project number 10493 - Improved Vaccination Strategy

Project number 70640 - Drug Carrier for Treatment of Cancer